GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiwanJ Pharmaceuticals Co Ltd (ROCO:6549) » Definitions » Cyclically Adjusted Price-to-FCF

TaiwanJ Pharmaceuticals Co (ROCO:6549) Cyclically Adjusted Price-to-FCF : (As of Jun. 05, 2025)


View and export this data going back to 2015. Start your Free Trial

What is TaiwanJ Pharmaceuticals Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


TaiwanJ Pharmaceuticals Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for TaiwanJ Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiwanJ Pharmaceuticals Co Cyclically Adjusted Price-to-FCF Chart

TaiwanJ Pharmaceuticals Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

TaiwanJ Pharmaceuticals Co Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of TaiwanJ Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, TaiwanJ Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TaiwanJ Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TaiwanJ Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where TaiwanJ Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

TaiwanJ Pharmaceuticals Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

TaiwanJ Pharmaceuticals Co's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec24 is calculated as:

For example, TaiwanJ Pharmaceuticals Co's adjusted Free Cash Flow per Share data for the fiscal year that ended in Dec24 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec24 (Change)*Current CPI (Dec24)
=-0.294/133.1571*133.1571
=-0.294

Current CPI (Dec24) = 133.1571.

TaiwanJ Pharmaceuticals Co Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201512 -5.018 99.792 -6.696
201612 -4.297 101.863 -5.617
201712 -3.174 104.011 -4.063
201812 -1.734 105.998 -2.178
201912 0.223 108.420 0.274
202012 -0.600 109.897 -0.727
202112 -0.133 117.630 -0.151
202212 -0.295 125.222 -0.314
202312 -0.030 129.419 -0.031
202412 -0.294 133.157 -0.294

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


TaiwanJ Pharmaceuticals Co  (ROCO:6549) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


TaiwanJ Pharmaceuticals Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of TaiwanJ Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


TaiwanJ Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 6-1, Shengyi Road, 3F-4, Section 2, Hsinchu County, Zhubei, TWN, 30261
TaiwanJ Pharmaceuticals Co Ltd is a Taiwan based specialty pharmaceutical company focused on small molecules for unmet medical needs like chronic organ inflammation of metabolic, autoimmune and infectious etiologies. It is also involved in developing novel chemical entities (NCEs) for chronic liver diseases and allergy/asthma.

TaiwanJ Pharmaceuticals Co Headlines

No Headlines